NCT01819428: NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma |
|
|
| Terminated | 2 | 22 | RoW | NOV120101 (Poziotinib), HM781-36B, Poziotinib | National OncoVenture, Hanmi Pharmaceutical Company Limited | Adenocarcinoma of Lung Stage IIIB, Adenocarcinoma of Lung Stage IV | 11/15 | 11/15 | | |
